Results 7,501-7,520 of 20,758 for speaker:Alan Kelly

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: I move amendment No. 53:In page 9, line 15, after “avert” to insert “or mitigate”. I will withdraw the amendment on the basis that the Minister will come back to us, having considered it and taken legal advice. Our strong advice is that it is too absolute and needs to be changed.

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: I move amendment No. 56:In page 9, to delete lines 23 to 28 and substitute the following:"(4) The obstetrician referred to in paragraph (a) of subsection (2) shall make such arrangements as he or she shall deem to be necessary for the carrying out as soon as may be of the termination of pregnancy to which the certification referred to in subsection (3) relates.". This brings us back to an...

Select Committee on Health: Health (Regulation of Termination of Pregnancy) Bill 2018: Committee Stage (6 Nov 2018)

Alan Kelly: The Chair may withdraw my name as my query has been clarified.

Written Answers — Department of Health: Hospital Charges (6 Nov 2018)

Alan Kelly: 568. To ask the Minister for Health the amount spent by the HSE in contracting debt collection agencies to pursue unpaid statutory charges in each of the years 2011 to 2017 and to date in 2018, in tabular form; and if he will make a statement on the matter. [44951/18]

Written Answers — Department of Health: Hospital Charges (6 Nov 2018)

Alan Kelly: 569. To ask the Minister for Health the costs incurred by each public hospital in contracting external debt collection agencies to pursue unpaid statutory charges in each of the years 2011 to 2017 and to date in 2018, in tabular form; and if he will make a statement on the matter. [44952/18]

Written Answers — Department of Health: Hospital Charges (6 Nov 2018)

Alan Kelly: 570. To ask the Minister for Health the number of inpatients or inpatient day cases with unpaid inpatient charges whose debt was referred to a debt collection or legal agency in each of the years 2011 to 2017 and to date in 2018, in tabular form; and if he will make a statement on the matter. [44953/18]

Written Answers — Department of Health: Hospital Charges (6 Nov 2018)

Alan Kelly: 571. To ask the Minister for Health the expenditure by the HSE and public hospitals on referral of statutory charges to external debt collection or legal agencies; and the breakdown of expenditure per charge, that is, inpatient charge, outpatient and emergency charge in each of the years 2011 to 2017 and to date in 2018. [44954/18]

Ceisteanna Eile - Other Questions: Economic Competitiveness (25 Oct 2018)

Alan Kelly: 10. To ask the Minister for Finance his plans to ensure Ireland protects its competitiveness and mitigates the risk of overheating pressures in the economy; and if he will make a statement on the matter. [43972/18]

Written Answers — Department of Finance: Credit Union Advisory Committee (25 Oct 2018)

Alan Kelly: 20. To ask the Minister for Finance the timescale for the conclusion of the Credit Union Advisory Committee's work; when it is next to report to him; the outstanding projects to be completed; and if he will make a statement on the matter. [43973/18]

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Medicinal Products Reimbursement (23 Oct 2018)

Alan Kelly: 67. To ask the Minister for Health when the agreement with a company (details supplied) will be completed regarding the treatment of 19 alpha 1 clinical trial patients; his plans to extend the treatment to all other alpha 1 patients; the timeline for same; and if he will make a statement on the matter. [43846/18]

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Medicinal Products Reimbursement (23 Oct 2018)

Alan Kelly: As the Minister will be aware, my neighbour, Ms Marion Kelly, passed away on 1 December last year. She was one of the 21 Alpha-1 patients on the clinical trial for Respreeza. In August 2017, the HSE said that it would not provide reimbursements for this drug. There was then a stand-off for a number of months when two patients, including Marion, passed away having been off the drug for six...

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Medicinal Products Reimbursement (23 Oct 2018)

Alan Kelly: I appreciate the honesty with which the Minister has addressed the question. Unfortunately, we have been at this juncture for a long time, and it is frustrating. The Minister met the family in April. We had a commitment from the HSE that there was going to be an agreement on the 19 patients quickly. Meetings were supposed to take place quickly but they did not happen. A meeting took...

Ceisteanna ar Sonraíodh Uain Dóibh - Priority Questions: Medicinal Products Reimbursement (23 Oct 2018)

Alan Kelly: I do not want to be here in a month asking the same question on the anniversary of Marion Kelly's passing. She died on 1 December, and she was in my office not long before she passed away. This is important for those who are fighting on behalf of the remaining 19 patients. I also acknowledge the work of Deputy Brassil on this matter. He tabled a parliamentary question to which the...

Written Answers — Department of Health: Medicinal Products Reimbursement (23 Oct 2018)

Alan Kelly: 151. To ask the Minister for Health when Respreeza will be sanctioned fully for persons that took part in the clinical trial; when it will be more widely available to alpha 1 antitripsan patients; and if he will make a statement on the matter. [43274/18]

Written Answers — Department of Health: Oireachtas Joint Committee Reports (23 Oct 2018)

Alan Kelly: 153. To ask the Minister for Health if he has considered the Oireachtas Joint Committee on Health's report on orphan drugs from February 2018; the changes he is considering on foot of same; and if he will make a statement on the matter. [43278/18]

Public Accounts Committee: HEA Financial Statements 2017 (18 Oct 2018)

Alan Kelly: I thank the witnesses. Best wishes to Dr. Love in the future. I am sorry to see him go. Best wishes to Paul O'Toole who is taking over his role. I used to work with him many years ago in Bord Fáilte. It is an excellent choice.

Public Accounts Committee: HEA Financial Statements 2017 (18 Oct 2018)

Alan Kelly: One might as well be upfront and say when one has worked with somebody. I have personal experience of working with the man. Dr. Love's openness on the issues is very welcome. It will serve us well. I welcome the fact that he is being so upfront on the issues today. It is quite obvious to all members of the committee, who have experience of the issues concerning the HEA, that there is a...

Public Accounts Committee: HEA Financial Statements 2017 (18 Oct 2018)

Alan Kelly: I appreciate that.

Public Accounts Committee: HEA Financial Statements 2017 (18 Oct 2018)

Alan Kelly: We know about that one.

Public Accounts Committee: HEA Financial Statements 2017 (18 Oct 2018)

Alan Kelly: Dr. Love is spot on. That is a fairly accurate and useful comment. Mr. Paul O'Toole is entering the role. Will he be as constrained as Dr. Love was? Are we in a vacuum whereby, from a regulatory point of view, nobody who is ever in Dr. Love's role will be able to deal with the issues in the way this committee expects or the public would require until this legislation is dealt with?